{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:51:27Z","timestamp":1781643087394,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Sheep serum agar (SSA) is a new serum-based medium developed as an alternative to Middlebrook 7H10 agar for the isolation of\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      from clinical samples and for use in antimicrobial susceptibility testing. This study aimed to evaluate the performance of SSA in primary anti-tuberculosis drug susceptibility testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 107\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      isolates with different susceptibility profiles were tested simultaneously against primary anti-tuberculosis agents on SSA and Middlebrook 7H10 agar using the proportion method. The findings were compared with those obtained using the BACTEC MGIT 960 (M960) method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The agreement between the M960 and 7H10 agar proportion method was determined as 93.45% for isoniazid (INH) and ethambutol (EMB), 96.26% for rifampicin (RIF), and 79.43% for streptomycin (STR), respectively. The agreement between the M960 and SSA proportion method was determined as 95.32% for INH, 97.19% for RIF, 92.52% for STR, and 86.91% for EMB, respectively. The agreement between the 7H10 agar proportion method and the SSA proportion method was determined as 98.13% for INH, 99.06% for RIF, 86.91% for STR, and 93.45% for EMB, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SSA medium was more effective at detecting INH, RIF and STR resistance than 7H10 agar. The results demonstrate the potential of SSA as an alternative medium to 7H10 agar. Further research is needed to confirm its reliability and evaluate its performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-04946-4","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:14:11Z","timestamp":1773364451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel serum-based medium for drug susceptibility testing of Mycobacterium tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Kubra","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemilenur","family":"Atas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Akif","family":"Gun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Kaynakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Yilmaz","family":"Coban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"4946_CR1","unstructured":"World Health Organization Global Tuberculosis Report. 2023. Geneva: World Health Organization; 2023."},{"key":"4946_CR2","unstructured":"World Health Organization Global Tuberculosis Report. 2024. Geneva: World Health Organization; 2024."},{"key":"4946_CR3","unstructured":"World Health Organization. https:\/\/www.who.int\/news\/item\/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis. Last accessed on 2 April 2025."},{"key":"4946_CR4","doi-asserted-by":"publisher","unstructured":"Bansal R, Sharma D, Singh R. Tuberculosis and its treatment: an overview. Mini Rev Med Chem. 2018;18(1):58-71. https:\/\/doi.org\/10.2174\/1389557516666160823160010. PMID: 27553018.","DOI":"10.2174\/1389557516666160823160010"},{"issue":"7","key":"4946_CR5","first-page":"564","volume":"3","author":"LB Heifets","year":"1999","unstructured":"Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis. 1999;3(7):564\u201381. PMID: 10423219.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"4946_CR6","first-page":"565","volume":"29","author":"G Canetti","year":"1963","unstructured":"Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler Ht, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ. 1963;29(5):565\u201378. PMID: 14102034; PMCID: PMC2555065.","journal-title":"Bull World Health Organ"},{"key":"4946_CR7","doi-asserted-by":"publisher","unstructured":"Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965;92(5):687-703. https:\/\/doi.org\/10.1164\/arrd.1965.92.5.687. PMID: 5321145.","DOI":"10.1164\/arrd.1965.92.5.687"},{"issue":"1","key":"4946_CR8","first-page":"21","volume":"41","author":"G Canetti","year":"1969","unstructured":"Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41(1):21\u201343. PMID: 5309084; PMCID: PMC2427409.","journal-title":"Bull World Health Organ"},{"key":"4946_CR9","volume-title":"Organization Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis","author":"World Health","year":"2018","unstructured":"World Health. Organization Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. Geneva: World Health Organization; 2018."},{"key":"4946_CR10","doi-asserted-by":"publisher","first-page":"39050","DOI":"10.1038\/srep39050","volume":"6","author":"AY Coban","year":"2016","unstructured":"Coban AY, Akbal AU, Bicmen C, Albay A, Sig AK, Uzun M, et al. Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Sci Rep. 2016;6:39050. https:\/\/doi.org\/10.1038\/srep39050. PMID: 27982061; PMCID: PMC5159858.","journal-title":"Sci Rep"},{"issue":"8","key":"4946_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1590\/0074-0276130697","volume":"108","author":"AY Coban","year":"2013","unstructured":"Coban AY, Uzun M. Rapid detection of multidrug-resistant Mycobacterium tuberculosis using the malachite green decolourisation assay. Mem Inst Oswaldo Cruz. 2013;108(8):1021\u20133. https:\/\/doi.org\/10.1590\/0074-0276130697. PMID: 24402143; PMCID: PMC4005540.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4946_CR12","doi-asserted-by":"publisher","unstructured":"De Logu A, Uda P, Pellerano ML, Pusceddu MC, Saddi B, Schivo ML. Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium. Eur J Clin Microbiol Infect Dis. 2001;20(1):33\u20139. https:\/\/doi.org\/10.1007\/pl00011234. PMID: 11245320.","DOI":"10.1007\/pl00011234"},{"key":"4946_CR13","doi-asserted-by":"publisher","unstructured":"Palomino JC, Martin A, Portaels F. Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods. Clin Microbiol Infect. 2007;13(8):754\u201362. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01698.x. Epub 2007 Mar 22. PMID: 17378933.","DOI":"10.1111\/j.1469-0691.2007.01698.x"},{"issue":"4","key":"4946_CR14","doi-asserted-by":"publisher","first-page":"116547","DOI":"10.1016\/j.diagmicrobio.2024.116547","volume":"110","author":"E Simsek","year":"2024","unstructured":"Simsek E, Yildirim K, Atas C, Coban AY. A rapid and simple modified nitrate reductase assay for testing first and second-line antituberculosis drug susceptibilities in Mycobacterium tuberculosis isolates. Diagn Microbiol Infect Dis. 2024;110(4):116547. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116547. Epub 2024 Sep 26. PMID: 39357107.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"4946_CR15","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1128\/JCM.37.4.1144-1149.1999","volume":"37","author":"PF Riska","year":"1999","unstructured":"Riska PF, Su Y, Bardarov S, Freundlich L, Sarkis G, Hatfull G, et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol. 1999;37(4):1144\u20139. https:\/\/doi.org\/10.1128\/JCM.37.4.1144-1149.1999. PMID: 10074539; PMCID: PMC88662.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"4946_CR16","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1128\/JCM.41.6.2647-2649.2003","volume":"41","author":"N Gal\u00ed","year":"2003","unstructured":"Gal\u00ed N, Dom\u00ednguez J, Blanco S, Prat C, Quesada MD, Matas L, et al. Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol. 2003;41(6):2647\u20139. https:\/\/doi.org\/10.1128\/JCM.41.6.2647-2649.2003. PMID: 12791894; PMCID: PMC156511.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"4946_CR17","first-page":"986","volume":"11","author":"CM Giampaglia","year":"2007","unstructured":"Giampaglia CM, Martins MC, Vieira GB, Vinhas SA, Telles MA, Palaci M, et al. Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2007;11(9):986\u201391. PMID: 17705976.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"4946_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41579-022-00721-0","volume":"20","author":"ES Chung","year":"2022","unstructured":"Chung ES, Johnson WC, Aldridge BB. Types and functions of heterogeneity in mycobacteria. Nat Rev Microbiol. 2022;20(9):529\u201341. https:\/\/doi.org\/10.1038\/s41579-022-00721-0. Epub 2022 Apr 1. PMID: 35365812; PMCID: PMC9681535.","journal-title":"Nat Rev Microbiol"},{"key":"4946_CR19","volume-title":"Tuberculosis laboratory biosafety manual","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Tuberculosis laboratory biosafety manual. Geneva: World Health Organization; 2012."},{"issue":"3","key":"4946_CR20","doi-asserted-by":"publisher","first-page":"e0031923","DOI":"10.1128\/spectrum.00319-23","volume":"11","author":"K Yildirim","year":"2023","unstructured":"Yildirim K, Atas C, Simsek E, Coban AY. The Effect of Inoculum Size on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis. Microbiol Spectr. 2023;11(3):e0031923. https:\/\/doi.org\/10.1128\/spectrum.00319-23. Epub 2023 May 22. PMID: 37212717; PMCID: PMC10269855.","journal-title":"Microbiol Spectr"},{"key":"4946_CR21","unstructured":"World Health. Organization Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). Geneva: World Health Organization; 2021."},{"issue":"1","key":"4946_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijmmb.2021.12.002","volume":"40","author":"AY Coban","year":"2022","unstructured":"Coban AY, Ceyhan I, Uzun M, Erkose Genc G, Bicmen C, Ozkutuk N, et al. Multicenter evaluation of AYC.2.2 agar for the isolation of mycobacteria from clinical samples. Indian J Med Microbiol. 2022;40(1):127\u201331. https:\/\/doi.org\/10.1016\/j.ijmmb.2021.12.002. Epub 2021 Dec 28. PMID: 34972569.","journal-title":"Indian J Med Microbiol"},{"key":"4946_CR23","doi-asserted-by":"publisher","unstructured":"Coban AY. Validation of a novel medium for drug susceptibility testing of Mycobacterium Tuberculosis against First- and Second-Line drugs: AYC.2.2 Agar and AYC.2.1 Broth. Int J Mycobacteriol. 2021;10(1):19-25. https:\/\/doi.org\/10.4103\/ijmy.ijmy_194_20. PMID: 33707367.","DOI":"10.4103\/ijmy.ijmy_194_20"},{"key":"4946_CR24","volume-title":"Staff- statistical guidance on reporting results from studies evaluating diagnostic tests","author":"Food and Drug Administration Guidance for Industry and FDA","year":"2007","unstructured":"Food and drug administration guidance for industry and FDA. Staff- statistical guidance on reporting results from studies evaluating diagnostic tests. USA: Food and Drug Administration; 2007."},{"key":"4946_CR25","doi-asserted-by":"publisher","unstructured":"Kontos F, Maniati M, Costopoulos C, Gitti Z, Nicolaou S, Petinaki E et al. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J Microbiol Methods. 2004;56(2):291-4. https:\/\/doi.org\/10.1016\/j.mimet.2003.10.015. PMID: 14744458.","DOI":"10.1016\/j.mimet.2003.10.015"},{"key":"4946_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1471-2334-12-369","volume":"12","author":"HM Said","year":"2012","unstructured":"Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, et al. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa. BMC Infect Dis. 2012;12:369. https:\/\/doi.org\/10.1186\/1471-2334-12-369. PMID: 23259765; PMCID: PMC3543708.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"4946_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10096-003-1030-3","volume":"22","author":"HJ Marttila","year":"2003","unstructured":"Marttila HJ, Marjam\u00e4ki M, Viljanen MK, Soini H. Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis. 2003;22(12):757\u20139. https:\/\/doi.org\/10.1007\/s10096-003-1030-3. Epub 2003 Nov 6. PMID: 14605940.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4946_CR28","doi-asserted-by":"publisher","unstructured":"Campelo TA, Cardoso de Sousa PR, Nogueira LL, Frota CC, Zuquim Antas PR. Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far? Access Microbiol. 2021;3(8):000245. https:\/\/doi.org\/10.1099\/acmi.0.000245. Erratum in: Access Microbiol. 2022;4(1):000294. 10.1099\/acmi.0.000294. PMID: 34595396; PMCID: PMC8479963.","DOI":"10.1099\/acmi.0.000245"},{"issue":"9","key":"4946_CR29","doi-asserted-by":"publisher","first-page":"e108911","DOI":"10.1371\/journal.pone.0108911","volume":"9","author":"S Christianson","year":"2014","unstructured":"Christianson S, Voth D, Wolfe J, Sharma MK. Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960. PLoS ONE. 2014;9(9):e108911. https:\/\/doi.org\/10.1371\/journal.pone.0108911. PMID: 25259734; PMCID: PMC4178229.","journal-title":"PLoS ONE"},{"issue":"2","key":"4946_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1128\/jcm.23.2.385-386.1986","volume":"23","author":"CL Woodley","year":"1986","unstructured":"Woodley CL. Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures. J Clin Microbiol. 1986;23(2):385\u20136. https:\/\/doi.org\/10.1128\/jcm.23.2.385-386.1986. PMID: 3084552; PMCID: PMC268651.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"4946_CR31","first-page":"748","volume":"6","author":"A Laszlo","year":"2002","unstructured":"Laszlo A, Rahman M, Espinal M, Raviglione M, WHO\/IUATLD Network of supranational reference laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO\/IUATLD supranational reference laboratory network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis. 2002;6(9):748\u201356. PMID: 12234129.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4946_CR32","volume-title":"Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement","author":"World Health Organization","year":"2008","unstructured":"World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement. Geneva: World Health Organization; 2008."},{"key":"4946_CR33","volume-title":"Use of liquid TB culture and drug susceptibility testing (DST) in low and medium income settings. Summary report of the expert group meeting on the use of liquid culture media","author":"World Health Organization","year":"2007","unstructured":"World Health Organization. Use of liquid TB culture and drug susceptibility testing (DST) in low and medium income settings. Summary report of the expert group meeting on the use of liquid culture media. Geneva: World Health Organization; 2007."},{"issue":"1","key":"4946_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1128\/JCM.02378-13","volume":"52","author":"S Banu","year":"2014","unstructured":"Banu S, Rahman SM, Khan MS, Ferdous SS, Ahmed S, Gratz J, et al. Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. J Clin Microbiol. 2014;52(1):156\u201363. https:\/\/doi.org\/10.1128\/JCM.02378-13. Epub 2013 Oct 30. PMID: 24172155; PMCID: PMC3911413.","journal-title":"J Clin Microbiol"},{"key":"4946_CR35","doi-asserted-by":"publisher","first-page":"e07552020","DOI":"10.1590\/0037-8682-0755-2020","volume":"54","author":"SCAD Silva","year":"2021","unstructured":"Silva SCAD, Vater MC, Ramalho DMP, Almeida IN, Miranda SS, Kritski A. Cost-effectiveness of Xpert\u00aeMTB\/RIF in the diagnosis of tuberculosis: pragmatic study. Rev Soc Bras Med Trop. 2021;54:e07552020. https:\/\/doi.org\/10.1590\/0037-8682-0755-2020. PMID: 33605382; PMCID: PMC7891564.","journal-title":"Rev Soc Bras Med Trop"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-04946-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04946-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-04946-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:52:06Z","timestamp":1781639526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-04946-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4946"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-04946-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}